Neuropathic Pain

Neurology·MeSH: Neuralgia

28 drugs in development·18 companies·7 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
Cymbalta®	ELI LILLY & Co (LLY)
duloxetine	Inventiva S.A. (IVA)
Nucynta ER	COLLEGIUM PHARMACEUTICAL, INC (COLL)
Nucynta ER and Nucynta IR	COLLEGIUM PHARMACEUTICAL, INC (COLL)

Phase 2(14)

Drug	Company
3,4-Methylenedioxymethamphetamine	AYTU BIOPHARMA, INC (AYTU)
3,4-Methylenedioxymethamphetamine	COLLEGIUM PHARMACEUTICAL, INC (COLL)
Capsaicin 8% Patch	Revance Therapeutics, Inc. (RVNC)
cemdomespib	REATA PHARMACEUTICALS INC (RETA)
halneuron	Dogwood Therapeutics, Inc. (DWTX)
IncobotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)
ly3848575	ELI LILLY & Co (LLY)
LY4065967	ELI LILLY & Co (LLY)
Methylphenidate	COLLEGIUM PHARMACEUTICAL, INC (COLL)
ok-101 0.05%	OKYO Pharma Ltd (OKYO)
ok-101 0.1%	OKYO Pharma Ltd (OKYO)
pilavapadin	LEXICON PHARMACEUTICALS, INC. (LXRX)
rta 901	REATA PHARMACEUTICALS INC (RETA)
rta 901	BIOGEN INC. (BIIB)

Phase 1(3)

Drug	Company
cc8464	Pelthos Therapeutics Inc. (PTHS)
ketamir-2	MIRA PHARMACEUTICALS, INC. (MIRA)
vx-993	VERTEX PHARMACEUTICALS INC / MA (VRTX)

Preclinical(3)

Drug	Company
activated cannabinoid	Phoenix Life Sciences International Limited. (PLSI)
feldetrex	PREMIER BIOMEDICAL INC (BIEI)
prtt-200	PROTECT PHARMACEUTICAL CORP (PRTT)

N/A(1)

Drug	Company
Methylphenidate	AYTU BIOPHARMA, INC (AYTU)

Phase 1/Phase 2(1)

Drug	Company
ST-503	SANGAMO THERAPEUTICS, INC (SGMO)

Phase 2/Phase 3(1)

Drug	Company
ath-1020	LeonaBio, Inc. (LONA)

Phase 4(1)

Drug	Company
Onabotulinum toxin A	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 28 drugs in development for Neuropathic Pain across 18 companies.

There are 7 clinical trials targeting Neuropathic Pain tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.